Clinically Significant Drug Interactions with Newer Antidepressants
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinically Significant Drug Interactions with Newer Antidepressants
Authors
Keywords
-
Journal
CNS DRUGS
Volume 26, Issue 1, Pages 39-67
Publisher
Springer Nature
Online
2011-11-19
DOI
10.2165/11594710-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract
- (2013) Filippo Caraci et al. CURRENT DRUG METABOLISM
- Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine
- (2011) Corbin J. Bachmeier et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Duloxetine
- (2011) Mary Pat Knadler et al. CLINICAL PHARMACOKINETICS
- Transporter-Mediated Drug–Drug Interactions
- (2011) L Zhang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Vilazodone
- (2011) James E. Frampton CNS DRUGS
- Focus on agomelatine
- (2011) Ben Green CURRENT MEDICAL RESEARCH AND OPINION
- Antidepressant Use in Geriatric Populations: The Burden of Side Effects and Interactions and Their Impact on Adherence and Costs
- (2010) Tami L. Mark et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers
- (2010) Adriana Rocha et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study
- (2010) Ian Douglas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Escitalopram
- (2010) Karly P. Garnock-Jones et al. CNS DRUGS
- The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper
- (2010) Randolph W. Evans et al. HEADACHE
- The use of antidepressants in clinical practice: focus on agomelatine
- (2010) R. H. McAllister-Williams et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Dose-Related Reduction in Bupropion Plasma Concentrations by Ritonavir
- (2010) Joohyun Park et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Noradrenergic Adverse Effects Due to Combined Treatment With Reboxetine and Triiodothyronine
- (2010) Rena Cooper-Kazaz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Clinically Relevant Pharmacokinetic Interaction Between Venlafaxine and Bupropion
- (2010) Georgios Paslakis et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effect of Adjunctive Duloxetine on the Plasma Concentrations of Clozapine, Olanzapine, and Risperidone in Patients With Psychotic Disorders
- (2010) Vincenza Santoro et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
- (2010) Christian de Bodinat et al. NATURE REVIEWS DRUG DISCOVERY
- Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome
- (2010) Katsutoshi Shioda et al. NEUROSCIENCE LETTERS
- Antidepressants: Clinically Relevant Drug Interactions to Be Considered
- (2010) Rene Schellander et al. PHARMACOLOGY
- The Effect of Coadministration of Duloxetine on Steady-State Serum Concentration of Risperidone and Aripiprazole: A Study Based on Therapeutic Drug Monitoring Data
- (2010) Magnhild Hendset et al. THERAPEUTIC DRUG MONITORING
- Selective Serotonin Reuptake Inhibitors Are Associated With a Modest Increase in the Risk of Upper Gastrointestinal Bleeding
- (2009) Laura E Targownik et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients
- (2009) Milka Hauta-Aho et al. ANNALS OF MEDICINE
- Interaction between clonidine and escitalopram
- (2009) M. Nikolić et al. BRITISH JOURNAL OF ANAESTHESIA
- An Association Between Selective Serotonin Reuptake Inhibitor Use and Serious Upper Gastrointestinal Bleeding
- (2009) Michael Dall et al. Clinical Gastroenterology and Hepatology
- Milnacipran
- (2009) Chi-Un Pae et al. CLINICAL NEUROPHARMACOLOGY
- In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine
- (2009) Evelyn D Lobo et al. CLINICAL PHARMACOKINETICS
- Escitalopram Is a Weak Inhibitor of the CYP2D6-Catalyzed O-Demethylation of (+)-Tramadol but Does Not Reduce the Hypoalgesic Effect in Experimental Pain
- (2009) L Noehr-Jensen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Desvenlafaxine: A new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder
- (2009) Richard Perry et al. CLINICAL THERAPEUTICS
- Duloxetine
- (2009) Natalie J. Carter et al. CNS DRUGS
- Mirtazapine
- (2009) Katherine F. Croom et al. CNS DRUGS
- Vilazodone: A 5-HT1AReceptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders
- (2009) Lee A. Dawson et al. CNS Neuroscience & Therapeutics
- Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants
- (2009) Xavier Vidal et al. DRUG SAFETY
- Interactions Between Herbal Medicines and Prescribed Drugs
- (2009) Angelo A. Izzo et al. DRUGS
- Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
- (2009) Arif Khan EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of Warfarin at Steady State in Healthy Subjects
- (2009) Jill Chappell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6
- (2009) Julie Eve Desmarais et al. JOURNAL OF CLINICAL PSYCHIATRY
- Venlafaxine Metabolism as a Marker of Cytochrome P450 Enzyme 2D6 Metabolizer Status
- (2009) Alice I. Nichols et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment
- (2009) Susanna M Wallerstedt et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram
- (2009) Johanna Hilli et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Influence of Comedication on Serum Concentrations of Aripiprazole and Dehydroaripiprazole
- (2009) Ragnhild Birkeland Waade et al. THERAPEUTIC DRUG MONITORING
- Rapid Clinical Induction of Hepatic Cytochrome P4502B6 Activity by Ritonavir
- (2008) E. D. Kharasch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk of Upper Gastrointestinal Tract Bleeding Associated With Selective Serotonin Reuptake Inhibitors and Venlafaxine Therapy
- (2008) Francisco J. de Abajo et al. ARCHIVES OF GENERAL PSYCHIATRY
- Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and Coumarins
- (2008) Tom Schalekamp ARCHIVES OF INTERNAL MEDICINE
- Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look
- (2008) Lucie Opatrny et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Steady-State Concentrations of Mirtazapine, N-Desmethylmirtazapine, 8-Hydroxymirtazapine and their Enantiomers in Relation to Cytochrome P450 2D6 Genotype, Age and Smoking Behaviour
- (2008) Anna-Britta Lind et al. CLINICAL PHARMACOKINETICS
- Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
- (2008) Edoardo Spina et al. CLINICAL THERAPEUTICS
- Desvenlafaxine Extended Release
- (2008) Lily P H Yang et al. CNS DRUGS
- An in Vitro Mechanistic Study to Elucidate the Desipramine/Bupropion Clinical Drug-Drug Interaction
- (2008) M. J. Reese et al. DRUG METABOLISM AND DISPOSITION
- An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects
- (2008) A. Patroneva et al. DRUG METABOLISM AND DISPOSITION
- Bupropion
- (2008) Sohita Dhillon et al. DRUGS
- Factors potentiating the risk of mirtazapine-associated restless legs syndrome
- (2008) Sung-Wan Kim et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults
- (2008) Alice I. Nichols et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Restless legs syndrome as side effect of second generation antidepressants
- (2008) Klaus G. Rottach et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The Influence of Smoking on the Serum Level of Duloxetine
- (2008) M. Fric et al. PHARMACOPSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started